Breaking News

Chimerix Appoints CEO

April 9, 2014

Berrey succeeds Moch

M. Michelle Berrey, M.D., M.P.H. has been appointed president and chief executive officer of Chimerix, Inc. Dr. Berrey will continue to serve as chief medical officer. Dr. Berrey succeeds Kenneth I. Moch, who has resigned to pursue other interests.
 
Prior to joining the company, Dr. Berrey served as chief medical officer at Pharmasset, Inc. since 2007, a company focused on the development of nucleotide analogs for the treatment of hepatitis C, until its acquisition by Gilead Sciences, Inc. in January 2012.
 
"We are grateful for Ken's contributions to Chimerix and his leadership during the company's transition to a publicly traded company. We are now entering a critical stage of the clinical development of brincidofovir. Our goal is to complete the requirements for regulatory approval of brincidofovir as rapidly as possible and we believe Dr. Berrey has the qualifications and expertise in abundance to accomplish that objective," said Ernest Mario, Ph.D., chairman of the board of directors. "I believe Dr. Berrey has demonstrated the leadership skills and vision to guide Chimerix through this critical phase in the company's evolution.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016